Showing 1 - 9 results of 9 for search 'Ruimin Hong', query time: 0.04s Refine Results
  1. 1
    Successful BCMA CAR-T Therapy for Multiple Myeloma With Central Nervous System Involvement Manifesting as Cauda Equina Syndrome—A Wandering Road to Remission

    Successful BCMA CAR-T Therapy for Multiple Myeloma With Central Nervous System Involvement Manifesting as Cauda Equina Syndrome—A Wandering Road to Remission by Yiyun Wang, Yiyun Wang, Yiyun Wang, Yiyun Wang, Linqin Wang, Linqin Wang, Linqin Wang, Linqin Wang, Yifan Zeng, Ruimin Hong, Ruimin Hong, Ruimin Hong, Ruimin Hong, Cheng Zu, Cheng Zu, Cheng Zu, Cheng Zu, Elaine Tan Su Yin, Elaine Tan Su Yin, Elaine Tan Su Yin, Elaine Tan Su Yin, Houli Zhao, Houli Zhao, Houli Zhao, Houli Zhao, Guoqing Wei, Guoqing Wei, Guoqing Wei, Guoqing Wei, Li Yang, Li Yang, Li Yang, Li Yang, Aiyun Jin, Aiyun Jin, Aiyun Jin, Aiyun Jin, Yongxian Hu, Yongxian Hu, Yongxian Hu, Yongxian Hu, He Huang, He Huang, He Huang, He Huang

    Published 2021-11-01
    Get full text
    Article
  2. 2
    Efficacy and Safety of Chimeric Antigen Receptor T Cells in Acute Lymphoblastic Leukemia With Post-Transplant Relapse

    Efficacy and Safety of Chimeric Antigen Receptor T Cells in Acute Lymphoblastic Leukemia With Post-Transplant Relapse by Lijuan Ding, Lijuan Ding, Lijuan Ding, Lijuan Ding, Yiyun Wang, Yiyun Wang, Yiyun Wang, Yiyun Wang, Ruimin Hong, Ruimin Hong, Ruimin Hong, Ruimin Hong, Houli Zhao, Houli Zhao, Houli Zhao, Houli Zhao, Linghui Zhou, Linghui Zhou, Linghui Zhou, Linghui Zhou, Guoqing Wei, Guoqing Wei, Guoqing Wei, Guoqing Wei, Wenjun Wu, Wenjun Wu, Wenjun Wu, Wenjun Wu, Huijun Xu, Huijun Xu, Huijun Xu, Huijun Xu, Yanlei Zhang, Yi Luo, Yi Luo, Yi Luo, Yi Luo, Jimin Shi, Jimin Shi, Jimin Shi, Jimin Shi, Alex H. Chang, Yongxian Hu, Yongxian Hu, Yongxian Hu, Yongxian Hu, He Huang, He Huang, He Huang, He Huang

    Published 2021-11-01
    Get full text
    Article
  3. 3
    Tumor Burden Measured by 18F-FDG PET/CT in Predicting Efficacy and Adverse Effects of Chimeric Antigen Receptor T-Cell Therapy in Non-Hodgkin Lymphoma

    Tumor Burden Measured by 18F-FDG PET/CT in Predicting Efficacy and Adverse Effects of Chimeric Antigen Receptor T-Cell Therapy in Non-Hodgkin Lymphoma by Ruimin Hong, Ruimin Hong, Ruimin Hong, Ruimin Hong, Elaine Tan Su Yin, Elaine Tan Su Yin, Elaine Tan Su Yin, Elaine Tan Su Yin, Linqin Wang, Linqin Wang, Linqin Wang, Linqin Wang, Xin Zhao, Linghui Zhou, Linghui Zhou, Linghui Zhou, Linghui Zhou, Guangfa Wang, Mingming Zhang, Mingming Zhang, Mingming Zhang, Mingming Zhang, Houli Zhao, Houli Zhao, Houli Zhao, Houli Zhao, Guoqing Wei, Guoqing Wei, Guoqing Wei, Guoqing Wei, Yiyun Wang, Yiyun Wang, Yiyun Wang, Yiyun Wang, Wenjun Wu, Wenjun Wu, Wenjun Wu, Wenjun Wu, Yafei Zhang, Fang Ni, Fang Ni, Fang Ni, Fang Ni, Yongxian Hu, Yongxian Hu, Yongxian Hu, Yongxian Hu, He Huang, He Huang, He Huang, He Huang, Kui Zhao

    Published 2021-08-01
    Get full text
    Article
  4. 4
    HLA Fully-Mismatched Sibling-Derived CD7 CAR-T Therapy Bridging to Haploidentical Hematopoietic Stem Cell Transplantation for Hepatosplenic γδ T-cell Lymphoma

    HLA Fully-Mismatched Sibling-Derived CD7 CAR-T Therapy Bridging to Haploidentical Hematopoietic Stem Cell Transplantation for Hepatosplenic γδ T-cell Lymphoma by Xueer Xu, Cheng Zu, Mingming Zhang, Pingnan Xiao, Ruimin Hong, Jingjing Feng, Huijun Xu, Jiazhen Cui, Jian Yu, Jimin Shi, Guoqing Wei, Alex H. Chang, He Huang, Yongxian Hu

    Published 2023-09-01
    Get full text
    Article
  5. 5
    Cytokine-based models for efficient differentiation between infection and cytokine release syndrome in patients with hematological malignancies

    Cytokine-based models for efficient differentiation between infection and cytokine release syndrome in patients with hematological malignancies by Linqin Wang, Yuqi Lv, Linghui Zhou, Shenghao Wu, Yuanyuan Zhu, Shan Fu, Shuyi Ding, Ruimin Hong, Mingming Zhang, Hanjing Yu, Alex H. Chang, Guoqing Wei, Yongxian Hu, He Huang

    Published 2024-03-01
    Get full text
    Article
  6. 6
    Safety and efficacy of CRISPR-based non-viral PD1 locus specifically integrated anti-CD19 CAR-T cells in patients with relapsed or refractory Non-Hodgkin's lymphoma: a first-in-human phase I studyResearch in context

    Safety and efficacy of CRISPR-based non-viral PD1 locus specifically integrated anti-CD19 CAR-T cells in patients with relapsed or refractory Non-Hodgkin's lymphoma: a first-in-hum... by Yongxian Hu, Cheng Zu, Mingming Zhang, Guoqing Wei, Wei Li, Shan Fu, Ruimin Hong, Linghui Zhou, Wenjun Wu, Jiazhen Cui, Dongrui Wang, Bing Du, Mingyao Liu, Jiqin Zhang, He Huang

    Published 2023-06-01
    Get full text
    Article
  7. 7
    Relapsed/Refractory Peripheral T-Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis With UNC13D and CD27 Germline Mutations

    Relapsed/Refractory Peripheral T-Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis With UNC13D and CD27 Germline Mutations by Tingting Yang, Rongrong Chen, Mingming Zhang, Ruirui Jing, Jia Geng, Guoqing Wei, Yi Luo, Pingnan Xiao, Ruimin Hong, Jingjing Feng, Shan Fu, Houli Zhao, Jiazhen Cui, Simao Huang, He Huang, Yongxian Hu

    Published 2024-01-01
    Get full text
    Article
  8. 8
    CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies

    CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies by Yongxian Hu, Jingjing Li, Fang Ni, Zhongli Yang, Xiaohua Gui, Zhiwei Bao, Houli Zhao, Guoqing Wei, Yiyun Wang, Mingming Zhang, Ruimin Hong, Linqin Wang, Wenjun Wu, Mohamad Mohty, Arnon Nagler, Alex H. Chang, Marcel R. M. van den Brink, Ming D. Li, He Huang

    Published 2022-09-01
    Get full text
    Article
  9. 9
    Author Correction: CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies

    Author Correction: CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies by Yongxian Hu, Jingjing Li, Fang Ni, Zhongli Yang, Xiaohua Gui, Zhiwei Bao, Houli Zhao, Guoqing Wei, Yiyun Wang, Mingming Zhang, Ruimin Hong, Linqin Wang, Wenjun Wu, Mohamad Mohty, Arnon Nagler, Alex H. Chang, Marcel R. M. van den Brink, Ming D. Li, He Huang

    Published 2024-03-01
    Get full text
    Article

Search Tools: